Cargando…
Naringin in Combination with Isothiocyanates as Liposomal Formulations Potentiates the Anti-inflammatory Activity in Different Acute and Chronic Animal Models of Rheumatoid Arthritis
[Image: see text] Combination of drugs is extensively used to treat chronic inflammatory disease. Naringin (NAR), sulforaphane (SFN), and phenethyl isothiocyanate (PEITC) are nutraceuticals with promising anti-inflammatory properties. However, their clinical effectiveness gets hindered because of lo...
Autores principales: | Mohanty, Sangeeta, Sahoo, Ashish Kumar, Konkimalla, V. Badireenath, Pal, Abhisek, Si, Sudam Chandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643286/ https://www.ncbi.nlm.nih.gov/pubmed/33163815 http://dx.doi.org/10.1021/acsomega.0c04300 |
Ejemplares similares
-
Correction to Naringin in Combination with Isothiocyanates
as Liposomal Formulations Potentiates the Anti-inflammatory Activity
in Different Acute and Chronic Animal Models of Rheumatoid Arthritis
por: Mohanty, Sangeeta, et al.
Publicado: (2021) -
Naringin as Sustained Delivery Nanoparticles Ameliorates
the Anti-inflammatory Activity in a Freund’s Complete Adjuvant-Induced
Arthritis Model
por: Mohanty, Sangeeta, et al.
Publicado: (2021) -
Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model
por: Haloi, Prakash, et al.
Publicado: (2023) -
Data on sulforaphane treatment mediated suppression of autoreactive, inflammatory M1 macrophages
por: Pal, Sanjima, et al.
Publicado: (2016) -
Therapeutic Effects of Naringin in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation
por: Aihaiti, Yirixiati, et al.
Publicado: (2021)